National Health Innovation Centre Singapore
Overview
National Health Innovation Centre Singapore is a nationally-appointed programme office that provides funding and strategic guidance to accelerate the commercialisation of healthcare innovations from Singapore's public research and clinical sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HiCura Medical | Nov 2024 | Grant | Co-investor |
| Plano | - | Accelerator | Co-investor |
| RNAscence Biotechnology | - | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Health Innovation Centre Singapore based?
National Health Innovation Centre Singapore is headquartered in Singapore, Singapore.
When was National Health Innovation Centre Singapore founded?
National Health Innovation Centre Singapore was founded in 2014.
How many portfolio companies does National Health Innovation Centre Singapore have?
National Health Innovation Centre Singapore has 3 portfolio companies in Caplight's dataset.
What are some companies in National Health Innovation Centre Singapore's portfolio?
Portfolio companies visible on Caplight include HiCura Medical, Plano, RNAscence Biotechnology.
What was National Health Innovation Centre Singapore's most recent investment shown here?
National Health Innovation Centre Singapore's most recent investment in this portfolio sample was in HiCura Medical in 2024.
What sectors does National Health Innovation Centre Singapore focus on?
National Health Innovation Centre Singapore focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does National Health Innovation Centre Singapore focus on?
National Health Innovation Centre Singapore typically invests at the Early stage.